The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Human Host Defense Peptide LL-37 Prevents Bacterial Biofilm Formation
Open accessAbstract
The ability to form biofilms is a critical factor in chronic infections by Pseudomonas aeruginosa and has made this bacterium a model organism with respect to biofilm formation. This study describes a new, previously unrecognized role for the human cationic host defense peptide LL-37. In addition to its key role in modulating the innate immune response and weak antimicrobial activity, LL-37 potently inhibited the formation of bacterial biofilms in vitro. This occurred at the very low and physiologically meaningful concentration of 0.5 μg/ml, far below that required to kill or inhibit growth (MIC = 64 μg/ml). LL-37 also affected existing, pregrown P. aeruginosa biofilms. Similar results were obtained using the bovine neutrophil peptide indolicidin, but no inhibitory effect on biofilm formation was detected using subinhibitory concentrations of the mouse peptide CRAMP, which shares 67% identity with LL-37, polymyxin B, or the bovine bactenecin homolog Bac2A. Using microarrays and follow-up studies, we were able to demonstrate that LL-37 affected biofilm formation by decreasing the attachment of bacterial cells, stimulating twitching motility, and influencing two major quorum sensing systems (Las and Rhl), leading to the downregulation of genes essential for biofilm development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 1×
“aeruginosa lung infections in CF patients (19, 48), examples of biofilm infections are chronic wound and sinus infections, ear infections, endocarditis, and medical device infections, including the colonization of catheters and implants such as joints or stents (11, 13, 23, 38).”
BackgroundBiofilms: Survival Mechanisms of Clinically Relevant Microorganisms
Donlan, R. M., & Costerton, J. W. (2002) · Clinical Microbiology Reviews · doi:10.1128/cmr.15.2.167-193.2002 · Cited by 6,644
Antibiotic resistance of bacteria in biofilms
Stewart, P. S., & William Costerton, J. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05321-1 · Cited by 4,585
Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen
Stover, C. K., Pham, X. Q., Erwin, A. L., Mizoguchi, S. D., Warrener, P., Hickey, M. J., Brinkman, F. S. L., Hufnagle, W. O., Kowalik, D. J., Lagrou, M., et al. (2000) · Nature · doi:10.1038/35023079 · Cited by 4,573
Self-citationCeri, H., Olson, M. E., Stremick, C., Read, R. R., Morck, D., & Buret, A. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1771-1776.1999 · Cited by 2,155
Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms
Singh, P. K., Schaefer, A. L., Parsek, M. R., Moninger, T. O., Welsh, M. J., & Greenberg, E. P. (2000) · Nature · doi:10.1038/35037627 · Cited by 1,519
Aminoglycoside antibiotics induce bacterial biofilm formation
Hoffman, L. R., D'Argenio, D. A., MacCoss, M. J., Zhang, Z., Jones, R. A., & Miller, S. I. (2005) · Nature · doi:10.1038/nature03912 · Cited by 1,321
LeVine, A. M., Kurak, K. E., Wright, J. R., Watford, W. T., Bruno, M. D., Ross, G. F., Whitsett, J. A., & Korfhagen, T. R. (1999) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.20.2.3303 · Cited by 1,273
Schuster, M., Lostroh, C. P., Ogi, T., & Greenberg, E. P. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2066-2079.2003 · Cited by 1,126
A component of innate immunity prevents bacterial biofilm development
Singh, P. K., Parsek, M. R., Greenberg, E. P., & Welsh, M. J. (2002) · Nature · doi:10.1038/417552a · Cited by 1,026
Pseudomonas biofilm formation and antibiotic resistance are linked to phenotypic variation
Drenkard, E., & Ausubel, F. M. (2002) · Nature · doi:10.1038/416740a · Cited by 997
The relationship between peptide structure and antibacterial activity
Powers, J.-P. S., & Hancock, R. E. W. (2003) · Peptides · doi:10.1016/j.peptides.2003.08.023 · Cited by 948
Self-citationWagner, V. E., Bushnell, D., Passador, L., Brooks, A. I., & Iglewski, B. H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.7.2080-2095.2003 · Cited by 920
Köhler, T., Curty, L. K., Barja, F., van Delden, C., & Pechère, J.-C. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.21.5990-5996.2000 · Cited by 852
Cationic host defense (antimicrobial) peptides
Brown, K. L., & Hancock, R. E. (2006) · Current Opinion in Immunology · doi:10.1016/j.coi.2005.11.004 · Cited by 839
Self-citation[6] Genetic approaches to study of biofilms
O'Toole, G. A., Pratt, L. A., Watnick, P. I., Newman, D. K., Weaver, V. B., & Kolter, R. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)10008-9 · Cited by 835
Schlegel, H. G., Kaltwasser, H., & Gottschalk, G. (1961) · Archives of Microbiology · doi:10.1007/bf00422356 · Cited by 785
Bals, R., Wang, X., Zasloff, M., & Wilson, J. M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9541 · Cited by 746
Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms
Friedman, L., & Kolter, R. (2004) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03877.x · Cited by 741
Kaneko, Y., Thoendel, M., Olakanmi, O., Britigan, B. E., & Singh, P. K. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30783 · Cited by 661
Antibiotics as intermicrobial signaling agents instead of weapons
Linares, J. F., Gustafsson, I., Baquero, F., & Martinez, J. L. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608949103 · Cited by 658
Chromek, M., Slamová, Z., Bergman, P., Kovács, L., Podracká, L., Ehrén, I., Hökfelt, T., Gudmundsson, G. H., Gallo, R. L., Agerberth, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1407 · Cited by 652
Screening for Quorum-Sensing Inhibitors (QSI) by Use of a Novel Genetic System, the QSI Selector
Rasmussen, T. B., Bjarnsholt, T., Skindersoe, M. E., Hentzer, M., Kristoffersen, P., Köte, M., Nielsen, J., Eberl, L., & Givskov, M. (2005) · Journal of Bacteriology · doi:10.1128/jb.187.5.1799-1814.2005 · Cited by 622
Shrout, J. D., Chopp, D. L., Just, C. L., Hentzer, M., Givskov, M., & Parsek, M. R. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05421.x · Cited by 573
Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus aureus -Derived Proteinases
Sieprawska-Lupa, M., Mydel, P., Krawczyk, K., Wójcik, K., Puklo, M., Lupa, B., Suder, P., Silberring, J., Reed, M., Pohl, J., et al. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.12.4673-4679.2004 · Cited by 551
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Hancock, R. E. W., & Speert, D. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0152 · Cited by 515
Self-citationBurn Wound Infections: Current Status
Pruitt, B. A., McManus, A. T., Kim, S. H., & Goodwin, C. W. (1998) · World Journal of Surgery · doi:10.1007/s002689900361 · Cited by 511
Identity and effects of quorum-sensing inhibitors produced by Penicillium species
Rasmussen, T. B., Skindersoe, M. E., Bjarnsholt, T., Phipps, R. K., Christensen, K. B., Jensen, P. O., Andersen, J. B., Koch, B., Larsen, T. O., Hentzer, M., et al. (2005) · Microbiology · doi:10.1099/mic.0.27715-0 · Cited by 469
Bjarnsholt, T., Jensen, P. Ø., Rasmussen, T. B., Christophersen, L., Calum, H., Hentzer, M., Hougen, H.-P., Rygaard, J., Moser, C., Eberl, L., et al. (2005) · Microbiology · doi:10.1099/mic.0.27955-0 · Cited by 440
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37
Schmidtchen, A., Frick, I., Andersson, E., Tapper, H., & Björck, L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03146.x · Cited by 439
Multiple Roles of Biosurfactants in Structural Biofilm Development by Pseudomonas aeruginosa
Pamp, S. J., & Tolker-Nielsen, T. (2007) · Journal of Bacteriology · doi:10.1128/jb.01515-06 · Cited by 404
Tjabringa, G. S., Aarbiou, J., Ninaber, D. K., Drijfhout, J. W., Sørensen, O. E., Borregaard, N., Rabe, K. F., & Hiemstra, P. S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6690 · Cited by 391
High-throughput generation of small antibacterial peptides with improved activity
Hilpert, K., Volkmer-Engert, R., Walter, T., & Hancock, R. E. W. (2005) · Nature Biotechnology · doi:10.1038/nbt1113 · Cited by 375
Self-citationImpact of LL-37 on anti-infective immunity
Bowdish, D. M. E., Davidson, D. J., Lau, Y. E., Lee, K., Scott, M. G., & Hancock, R. E. W. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0704380 · Cited by 374
Self-citationOverhage, J., Bains, M., Brazas, M. D., & Hancock, R. E. W. (2008) · Journal of Bacteriology · doi:10.1128/jb.01659-07 · Cited by 358
Self-citationand the in vitroand in vivo biofilm mode of growth
Høiby, N., Krogh Johansen, H., Moser, C., Song, Z., Ciofu, O., & Kharazmi, A. (2001) · Microbes and Infection · doi:10.1016/s1286-4579(00)01349-6 · Cited by 356
Immunomodulatory Activities of Small Host Defense Peptides
Bowdish, D. M. E., Davidson, D. J., Scott, M. G., & Hancock, R. E. W. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1727-1732.2005 · Cited by 316
Self-citationUse of Intrinsic Optical Signals to Monitor Physiological Changes in Brain Tissue Slices
Aitken, P. G., Fayuk, D., Somjen, G. G., & Turner, D. A. (1999) · Methods · doi:10.1006/meth.1999.0762 · Cited by 273
Novel Pseudomonas aeruginosa Quorum-Sensing Inhibitors Identified in an Ultra-High-Throughput Screen
Müh, U., Schuster, M., Heim, R., Singh, A., Olson, E. R., & Greenberg, E. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00665-06 · Cited by 259
Synergistic Interactions between Mammalian Antimicrobial Defense Peptides
Yan, H., & Hancock, R. E. W. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1558-1560.2001 · Cited by 259
Self-citationMcPhee, J. B., Bains, M., Winsor, G., Lewenza, S., Kwasnicka, A., Brazas, M. D., Brinkman, F. S. L., & Hancock, R. E. W. (2006) · Journal of Bacteriology · doi:10.1128/jb.00053-06 · Cited by 225
Self-citationPulmonary infections in patients with cystic fibrosis
RAJAN, S. (2002) · Seminars in Respiratory Infections · doi:10.1053/srin.2002.31690 · Cited by 220
Macfarlane, E. L. A., Kwasnicka, A., & Hancock, R. E. W. (2000) · Microbiology · doi:10.1099/00221287-146-10-2543 · Cited by 209
Self-citationOverhage, J., Lewenza, S., Marr, A. K., & Hancock, R. E. W. (2007) · Journal of Bacteriology · doi:10.1128/jb.01623-06 · Cited by 200
Self-citationBiofilms, Antimicrobial Resistance, and Airway Infection
Prince, A. S. (2002) · New England Journal of Medicine · doi:10.1056/nejmcibr021776 · Cited by 177
Britigan, B. E., Hayek, M. B., Doebbeling, B. N., & Fick, R. B. (1993) · Infection and Immunity · doi:10.1128/iai.61.12.5049-5055.1993 · Cited by 156
Andersen, J. H., Jenssen, H., & Gutteberg, T. J. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00214-0 · Cited by 136
High-Throughput Screens for Small-Molecule Inhibitors of Pseudomonas aeruginosa Biofilm Development
Junker, L. M., & Clardy, J. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00506-07 · Cited by 126
Overhage, J., Schemionek, M., Webb, J. S., & Rehm, B. H. A. (2005) · Applied and Environmental Microbiology · doi:10.1128/aem.71.8.4407-4413.2005 · Cited by 119
Self-citationPathogenicity of microbes associated with cystic fibrosis
Hutchison, M. L., & Govan, J. R. W. (1999) · Microbes and Infection · doi:10.1016/s1286-4579(99)80518-8 · Cited by 116
Improved Derivatives of Bactenecin, a Cyclic Dodecameric Antimicrobial Cationic Peptide
Wu, M., & Hancock, R. E. W. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.5.1274 · Cited by 112
Self-citationBrogden, K. A., Kalfa, V. C., Ackermann, M. R., Palmquist, D. E., McCray, P. B., & Tack, B. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.1.331-334.2001 · Cited by 95
What Keeps the Urinary Tract Sterile?
Chromek, M., Slamová, Z., Bergman, P., Kovács, L., Podracká, L., Ehrén, I., Hökfelt, T., Gudmundsson, G., Gallo, R. L., Agerberth, B., et al. (2006) · Journal of the American Society of Nephrology · doi:10.1681/01.asn.0000926856.92699.53 · Cited by 95
Microbial motility involvement in biofilm structure formation – a 3D modelling study
Picioreanu, C., Kreft, J., Klausen, M., Haagensen, J. A. J., Tolker‐Nielsen, T., & Molin, S. (2007) · Water Science & Technology · doi:10.2166/wst.2007.275 · Cited by 85
Cited by
Roy, R., Tiwari, M., Donelli, G., & Tiwari, V. (2018) · Virulence · doi:10.1080/21505594.2017.1313372 · Cited by 1,523
Bahar, A., & Ren, D. (2013) · Pharmaceuticals · doi:10.3390/ph6121543 · Cited by 1,351
Pseudomonas aeruginosa: all roads lead to resistance
Breidenstein, E. B. M., de la Fuente-Núñez, C., & Hancock, R. E. W. (2011) · Trends in Microbiology · doi:10.1016/j.tim.2011.04.005 · Cited by 1,286
Self-citationHurdle, J. G., O'Neill, A. J., Chopra, I., & Lee, R. E. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2474 · Cited by 871
de la Fuente-Núñez, C., Reffuveille, F., Fernández, L., & Hancock, R. E. (2013) · Current Opinion in Microbiology · doi:10.1016/j.mib.2013.06.013 · Cited by 801
Self-citation
Metadata
- Authors
- Overhage, J., Campisano, A., Bains, M., Torfs, E. C. W., Rehm, B. H. A., & Hancock, R. E. W.
- Venue
- Infection and Immunity
- Publisher
- American Society for Microbiology
- Published
- 2008-09
- Volume
- 76
- Issue
- 9
- Pages
- 4176-4182
- ISSN
- 0019-9567 (ISSN-L)
- 1098-5522
- OpenAlex
- W2143256071
- Cited by
- 696
- References
- 54
- FWCI
- 8.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.